Long-term Outcomes Better for Those Who Stop Taking Antipsychotics

0
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.

Study Highlights Difficulty of Antipsychotic Withdrawal

0
New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.
Young man refusing to take prescribed pills in clinic

Antipsychotics Lead to Worse Outcomes in First-Episode Psychosis

23
Those who did not get antipsychotics in the first month were almost twice as likely to be in recovery after five years.

Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain

90
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

A Short History of Tardive Dyskinesia: 65 Years of Drug-Induced Brain Damage That Rolls...

92
Psychiatry has long turned a blind eye to the full scope of harm associated with TD. New TD drugs "work" by further impairing brain function.
Illustration of man sitting on a red and white pill. He holds his head with pain symbols in the air above him.

Adding Antipsychotics Worsens Outcomes in Psychotic Depression

14
Outcomes were worse for all, with young people on combination therapy twice as likely to experience rehospitalization or death by suicide than those on antidepressants alone.

Despite Safety Risks, Prescribers Receive Little Guidance of Monitoring Antipsychotic Clozapine

5
A new review finds a lack of available guidance on how to effectively monitor adverse effects of antipsychotic drug clozapine.

Antipsychotics Increase Risk of Dementia; New Research Illuminates Why

16
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.

Recovery Rate Six Times Higher For Those Who Stop Antipsychotics Within Two Years

62
People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.

Contribution of Antipsychotics to Suicidality and Depression

3
Peter Lehmann reviews the contribution of antipsychotics to suicide and depression in schizophrenia in the current International Journal of Psychotherapy.  Publications about the intrinsic effects of...

Do Antipsychotics Protect Against Early Death? A Review of the Evidence

75
Psychiatry is now claiming that research has shown that antipsychotics reduce mortality among the seriously mentally ill. A critical review of the literature reveals that this claim is best described as the the field's latest "delusion" about the merits of these drugs.

Psychiatry Defends Its Antipsychotics: A Case Study of Institutional Corruption

153
Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.

Antipsychotic Dose Reduction Linked To Long-term Improvements In First-Episode Schizophrenia Patients

12
Careful reductions in dosage levels of antipsychotic medications over time improved long-term rates of recovery and functional remission in patients diagnosed with a first-episode psychosis.

An FDA Whistleblower’s Documents: Commerce, Corruption, and Death

186
In 2008, a reviewer of psychiatric drugs at the FDA, Ron Kavanagh, complained to Congress that the FDA was approving a new antipsychotic that was ineffective and yet had adverse effects that increased the risk of death. Twelve years later, a review of the whistleblower documents reveal an FDA approval process that can lead to the marketing of drugs sure to harm public health.

Withdrawal from Antipsychotics

0
A review of the scientific literature related to the withdrawal of antipsychotics: animal studies, withdrawal symptoms, tapering success rates, and consumer accounts of discontinuation.

For People “At Risk for Psychosis,” Antipsychotics Associated with Worse Outcomes

27
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

The Case Against Antipsychotics

130
This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.

Researchers Warn of “Brain Atrophy” in Children Prescribed Antipsychotics

20
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

Vitamin B6 Effective in Reducing Antipsychotic Induced Akathisia

9
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.

The Charade of New Drug Approvals for Schizophrenia

92
The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.

The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia

67
The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.

Anticholinergic Psychiatric Drugs Linked to a 50% Increase in Dementia

17
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.

Very Slow Taper Best for Antipsychotic Discontinuation

13
An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.
Letter blocks spelling "CANCER" and spilled pills in various colors on a white background

Cancer Risk Higher for Those on Clozapine

3
The antipsychotic clozapine, considered the “gold-standard” treatment for psychosis, was found to increase the risk of blood and lymph system cancers.

Antipsychotics Worsen Cognitive Functioning in First-Episode Psychosis

1
Withholding antipsychotics may be beneficial for memory, the researchers write.